PRGO News and Press, Perrigo Company plc From 04/07/20

DUBLIN , April 7, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today preliminary unaudited first quarter 2020 net sales and provided GAAP and non-GAAP operating income for the first quarter. Perrigo CEO and President, Murray S. Kessler c...

DUBLIN , April 6, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it was the first to receive approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for over-the-counter ("OTC") diclofenac sodium topical gel 1%....

DUBLIN , April 2, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has completed the acquisition of the oral self-care assets of High Ridge Brands. The acquisition underscores the numerous bolt-on opportunities that are advancing Perrigo's commitmen...

The Food and Drug Administration has requested that Sanofi (NASDAQ: SNY) recall all of its Zantac heartburn products because the agency found that the amount of N-Nitrosodimethylamine (NDMA) in those products increases over time and when they are stored at higher than room temperatures. Whil...

The FDA is requesting all manufacturers of ranitidine drugs to withdraw them immediately from the U.S. market due to the presence of an impurity called N-Nitrosodimethylamine (NDMA), a suspected carcinogen. More news on: GlaxoSmithKline plc, Amneal Pharmaceuticals, Inc., Mylan N.V., Heal...

New York City, NY:March 26, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Baby Formula Nutritions Products Market in Global Industry: 2020 Research and New Innovations in Food and Beverages Sector. The prime objective of the report is to of...

Compugen (NASDAQ: CGEN ) initiated with Buy rating and $16 (156% upside) price target at SunTrust. Shares up  9%  premarket. More news on: Compugen Ltd., Incyte Corporation, NextCure, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Ascendis Pharma (NASDAQ: ASND ) initiated with Outperform rating with a $199 (97% upside) price target at Oppenheimer. More news on: Ascendis Pharma A/S, Livongo Health, Inc., Cardinal Health, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Osmotica Pharmaceuticals (NASDAQ: OSMT ) initiated with Buy rating and $8 (74% upside) price target at SunTrust. More news on: Osmotica Pharmaceuticals plc, Epizyme, Inc., Baxter International Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...